HOME >> MEDICINE >> NEWS
Case School of Engineering professor applies virtual reality to train brain and heart surgeons

CLEVELAND Virtual reality simulation tools are already revolutionizing the way dentists are taught at Case Western Reserve University and if M. Cenk Cavusoglu has his way, simulation technology at Case will also train the world's brain and heart surgeons.

"Simulation is a popular training tool because it reduces the learning time and allows students to learn independently," said Cavusoglu, an assistant professor of electrical engineering and computer science at the Case School of Engineering.

Prior to joining Case in 2002, Cavusoglu helped to develop sophisticated laparoscopic and endoscopic tools in the Robotics and Intelligent Machine Lab at the University of California at Berkeley. Laparoscopy and endoscopy enable doctors to treat diseased organs and tissue and remove cysts and tumors through tiny rather than major incisions and often with local rather than general anesthesia. The challenge now, he says, is to expand these minimally invasive techniques to complex surgeries, and he intends to close that gap.

Cavusoglu and his colleagues at Case and other institutions nationwide are applying engineering, computer science and biomedical expertise to develop the simulation technology and open architecture software necessary for simulation technology. They also are experimenting with soft tissue models and "haptics" technology to replicate the appearance and functions of the heart and brain, and enable doctors to "feel" when they accomplish procedures correctly.

"Laparoscopy requires a different skill set than open surgery," Cavusoglu explains. "Surgeons typically view patients from the outside in. When a laparoscopic camera is inserted, they see patients from the inside out. Hand/eye coordination is difficult to master. Practice on a simulator would allow surgeons to perfect their technique with no risk to patients."

Another undertaking Cavusoglu's "robotic beating heart surgery" project is also advancing surgical science. In a joint
'"/>

Contact: Laura Massie
laura.massie@case.edu
216-368-4442
Case Western Reserve University
1-Mar-2006


Page: 1 2

Related medicine news :

1. Adding medication improves recovery for elderly with depression, says Pitt School of Medicine study
2. Boston University School of Medicine faculty member receives honorary degree from alma mater
3. Cigarette use may explain asthma epidemic in children, says Mailman School of Public Health study
4. Mailman School of Public Health researchers analyze air quality and weather changes by 2050
5. Menzies School of Health Research receives $5.3 million in Federal Budget
6. Howe School lecture -- Changing the Management of Drug Safety and Pharmacovigilance, May 3
7. NIH-funded program co-directed by Mailman School of PH faculty to expedite clinical research process
8. Men with no sons more at risk for prostate cancer, according to Mailman School of PH Study
9. Yale School of Medicine awarded $57 million for bench-to-bedside research
10. Schools should take the lead in increasing kids activity
11. Mount Sinai School of Medicine receives prestigious AAMC Grant for Chronic Illness Care education

Post Your Comments:
(Date:5/21/2013)... Dr. James C. Wittig, Chief of Orthopedic ... Division of the John Theurer Cancer Center at Hackensack ... one of the top 13 Orthopedic Oncologists in the ... is one of approximately 125 surgeons in America who ... surveying thought leaders in the field of Oncology. Dr. ...
(Date:5/21/2013)... Chicago, IL (PRWEB) May 21, 2013 ... information on the site for patients taking the blood ... drug may be at more risk of death when ... , DrugRisks was created to improve the safety of ... warnings, recalls, studies and legal news. Visitors can see ...
(Date:5/20/2013)... The India Network Foundation, a ... insurance, announces a new pre-existing condition coverage plan: ... the years, India Network members have requested a ... maximums, and duration. The Platinum Comprehensive Plan is ... the valuable coverage and benefits of a PPO ...
(Date:5/20/2013)... Southfield, Michigan (PRWEB) May 21, 2013 This ... National Dog Bite Prevention Week (May 19th-May 25th) is an ... dog bite attacks and by encouraging dog owners to properly ... a dog. , Michigan dog bite lawyers at ... animal attacks in cases throughout Michigan. The personal injury law ...
(Date:5/20/2013)... May 20, 2013 When people ... not always to become a celebrity. New Jersey ... 2013 ABC News report (“Chris Christie Says Lap ... clear that the surgery was not done so ... gain celebrity status as a former lap band ...
Breaking Medicine News(10 mins):Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 2Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 3Health News:DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding 2Health News:Indian Network announces Platinum Comprehensive Visitor Health Insurance Plan with Pre-existing Condition Choices for Visitors on Short Term Trip to the United States 2Health News:Indian Network announces Platinum Comprehensive Visitor Health Insurance Plan with Pre-existing Condition Choices for Visitors on Short Term Trip to the United States 3Health News:Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 3
(Date:5/21/2013)... 2013 Reportlinker.com announces that a ... its catalogue:   ... Medical Devices in the US Market ... Changing Regulatory and Reimbursement Scenario for ...   Summary ...
(Date:5/21/2013)... , May 21, 2013 Ceregene, ... secondary analysis of its double-blind, randomized, controlled Phase ... a gene therapy product designed to deliver the ... analysis identified a more robust response to CERE-120 ... to treatment relative to those diagnosed 10 years ...
(Date:5/21/2013)... Calif. , May 21, 2013 /PRNewswire/ ... ), a specialty pharmaceutical company focused on ... for the treatment of acute and breakthrough ... in a placebo-controlled Phase 3 study of ... analgesia) System (NanoTab System), the primary efficacy ...
Breaking Medicine Technology:Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10
Cached News: